Martin D. Williams
Founder at Yuma Therapeutics Corp.
Profile
Martin D.
Williams is the founder of Yuma Therapeutics Corp.
which was founded in 2009.
He is currently the Chief Executive Officer & Director at Caraway Therapeutics, Inc. He also held positions at Pentose Pharmaceuticals, Inc., Wyeth LLC, Synta Pharmaceuticals Corp., Dicerna Pharmaceuticals, Inc., and Hoffmann-La Roche, Inc. Mr. Williams has an MBA degree from Harvard University, a graduate degree from The University of Manchester, and an undergraduate degree from The University of Lincoln.
Martin D. Williams active positions
| Companies | Position | Start |
|---|---|---|
Yuma Therapeutics Corp.
 Yuma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Yuma Therapeutics Corp. operates as a biopharmaceutical company. It develops novel disease-modifying small molecule compounds that modulate cellular proteostasis to treat neurodegenerative proteinopathies. The company was founded by Yukari Y. Perrella and Martin D. Williams in 2009 and is headquartered in Cambridge, MA. | Founder | 31/12/2008 |
Caraway Therapeutics, Inc.
 Caraway Therapeutics, Inc. BiotechnologyHealth Technology Caraway Therapeutics, Inc. provides heathcare services. The company was founded by Timothy Harris, Wade Harper ,Ivan Dikic ,Tony Hyman and is headquartered in Cambridge, MA. | Chief Executive Officer | - |
Former positions of Martin D. Williams
| Companies | Position | End |
|---|---|---|
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | President | 27/03/2013 |
Altus Pharmaceuticals, Inc.
 Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 30/11/2005 |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Sales & Marketing | 31/05/2004 |
| U.S. Marketer, Inc. | President | 28/02/2001 |
Pentose Pharmaceuticals, Inc.
 Pentose Pharmaceuticals, Inc. BiotechnologyHealth Technology Pentose Pharmaceuticals, Inc. develops and commercializes novel antiviral products for medical use based on innovative applications of nucleic acid chemistry. Pentose is a privately held biopharmaceutical company founded in 1995 and is based in Cambridge, Massachusetts. | Sales & Marketing | 31/12/1998 |
Training of Martin D. Williams
| Harvard University | Masters Business Admin |
| The University of Manchester | Graduate Degree |
| The University of Lincoln | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Pentose Pharmaceuticals, Inc.
Pentose Pharmaceuticals, Inc. BiotechnologyHealth Technology Pentose Pharmaceuticals, Inc. develops and commercializes novel antiviral products for medical use based on innovative applications of nucleic acid chemistry. Pentose is a privately held biopharmaceutical company founded in 1995 and is based in Cambridge, Massachusetts. | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Commercial Services |
| U.S. Marketer, Inc. | |
Yuma Therapeutics Corp.
Yuma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Yuma Therapeutics Corp. operates as a biopharmaceutical company. It develops novel disease-modifying small molecule compounds that modulate cellular proteostasis to treat neurodegenerative proteinopathies. The company was founded by Yukari Y. Perrella and Martin D. Williams in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Caraway Therapeutics, Inc.
Caraway Therapeutics, Inc. BiotechnologyHealth Technology Caraway Therapeutics, Inc. provides heathcare services. The company was founded by Timothy Harris, Wade Harper ,Ivan Dikic ,Tony Hyman and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Martin D. Williams
